Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts

J Eur Acad Dermatol Venereol. 2021 Jun;35(6):e362-e365. doi: 10.1111/jdv.17237. Epub 2021 Apr 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anaphylaxis*
  • COVID-19 Vaccines
  • COVID-19*
  • Dermatitis, Atopic* / prevention & control
  • Humans
  • SARS-CoV-2
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • Vaccines